Gilead’s Seladelpar Demonstrated a Sustained and Consistent Long-Term Efficacy and Safety Profile in Primary Biliary Cholangitis

View Full Size 

Download

• Full Size JPEG, 1728x576, 135.2 KB
• Small JPEG, 480x160, 43.3 KB
• Preview JPEG, 144x48, 19.2 KB
• Thumbnail JPEG, 120x40, 17.6 KB